Etyczne uregulowania kontaktów studentów medycyny z firmami farmaceutycznymi w Stanach Zjednoczonych

• Autorzy: Marta Makowska

Warianty tytułu

Ethical Regulation of Medical Students' Interactions with the Pharmaceutical Industry in the United States

• Języki publikacji: PL

Abstrakty

W poniższym artykule zostaną zaprezentowane wyniki amerykańskich badań dotyczące kontaktów studentów medycyny z firmami farmaceutycznymi - zostanie pokazany charakter tych kontaktów, ich częstotliwość i potencjalne oddziaływanie na ich przyszłe decyzje preskrypcyjne. Ponadto zostaną również przedstawione przyczyny i sposoby uregulowania tych interakcji. Omówione będą wskazówki, które wydały: Stowarzyszenie Amerykańskich Szkół Medycznych (ang. Association of American Medical Colleges), Instytut Medycyny (ang. Institute of Medicine) i Stowarzyszenie Amerykańskich Studentów Medycyny (ang. American Medical Student Association). Na końcu zostaną omówione zmiany, do jakich doprowadziły zalecenia. W USA nie istnieją tak surowe federalne uregulowania prawne dotyczące marketingu farmaceutycznego, jak to ma miejsce w Unii Europejskiej, dlatego też regulacje etyczne, choć niemające mocy prawnej, są tu niezwykle istotne. (fragment tekstu)

EN

The involvement of the pharmaceutical industry in medical education can be seen as something completely natural. Who better than the producer of the medicine would know how the drug was developed, how the process of it being authorized for sale proceeded, and what the side effects of it are? Today in the United States, more and more colleges are implementing strong pharmaceutical conflict-of-interest policies. Interaction between students and medical school staff with these companies is undesirable, because they share marketing materials more often than honest data, and their representatives use various ways to influence these current and future physicians during their meetings. This article will describe research which shows what pharmaceutical marketing directed at students looks like in the USA - its character, frequency, and potential impact on future medical decisions. Also, ways of regulating interaction between medical schools, their staff and students and the pharmaceutical industry will be expressed. Guidelines of the Association of American Medical Colleges, the Institute of Medicine and the American Medical Student Association will be described. At the end, questions about their influence on reality and whether medical schools' policies can be an effective barrier for pharmaceutical marketing on medical schools will be asked. (original abstract)

Słowa kluczowe

PL

Rynek farmaceutyczny; Etyka działalności gospodarczej; Studenci; Konflikt interesów

EN

Pharmaceutical market; Business activity ethics; Students; Interests conflict

• Czasopismo: Annales : etyka w życiu gospodarczym
• Rocznik: 2014
• Tom: 17
• Numer: nr 3
• Strony: 125--137

Twórcy

autor

Marta Makowska

• Szkoła Główna Gospodarstwa Wiejskiego w Warszawie

Bibliografia

• American Medical Student Association, History, AMSA 2012, http://www.pharmfree.org/campaign?id=0004.
• American Medical Student Association, Scorecard, AMSA 2013, http://www.amsascorecard.org.
• American Medical Student Association, The Campaign, AMSA 2012, http://www.pharmfree.org/campaign/.
• American Medical Student Association. Evidence and Recommendations for a Model Pharm-free Curriculum. AMSA, http://www.pharmfree.org/tools/resources_documents/files/ModelPharmFreeCurriculum_Final-1.pdf.
• Association of American Medical Colleges, Industry Fundning of Medical Education, AAMC 2008, https://www.aamc.org/download/157370/data/industry_funding_report.pdf.
• Austad K., Avorn J., Franklin J., Kowal M., Campbell E.G., Kesselheim A., Changing Interactions Between Physician Trainees and the Pharmaceutical Industry: A National Survey, "Journal of General Internal Medicine" 2013, No. 28 (8), s. 1064-1071. doi:10.1007/s11606-013-2361-0.
• Bellin M., McCarthy S., Drevlow L., Pierach C., Medical Students' Exposure to Pharmaceutical Industry Marketing. A Survey at One U.S. Medical School, "Academic Medicine" 2004, No. 79 (11), s. 1041-1045.
• Brody H., The Company We Keep: Why Physicians Should Refuse to See Pharmaceutical Representatives, "Annals of Family Medicine" 2005, No. 3, s. 82-85.
• Carmody D., Mansfield P.R., What Do Medical Students Think about Pharmaceutical Promotion?, "Australian Medical Student Journal" 2010, No. 1(1), s. 54-57.
• Carroll A.E., Vreeman R.C., Buddenbaum J., Inu T., To What Extent Do Educational Interventions Impact Medical Trainees' Attitudes and Behaviors Regarding Industry-trainee and Industry-physician Relationships?, "Pediatrics" 2007, No. 120 (6), s. 1528-1535.
• Cialdini R.B., Wywieranie wpływu na ludzi, GWP, Gdańsk 2003.
• Fein E.H., Vermillion M.L., Uijtdehaage S.H.J., Pre-Clinical Medical Students' Exposure to and Attitudes Toward Pharmaceutical Industry S.H. Marketing, "Medical Education Online" 2007, No. 12 (8), s. 2.
• Fitz M.M., Homan D., Reddy S., Griffith C.H., Baker E., Simpson K., The Hidden Curriculum: Medical Students' Changing Opinions toward the Pharmaceutical Industry, "Academic Medicine" 2007, No. 82 (10 Supp.), s. S1-3.
• Hyman P.L., Hochman M.E., Shaw J., Steinman M.A., Attitudes of Preclinical and Clinical Medical Students Toward Interactions with the Pharmaceutical Industry, "Academic Medicine" 2007, No. 84(1), s. 94-99. doi: 10.1097/01.ACM.0000249907.88740.ef
• Lo B., Field M. (red.), Conflict of Interest in Medical Research, Education, and Practice, Institute of Medicine (US), The National Academies Press, Washington DC 2009.
• Makowska M., Etyczne standardy marketingu farmaceutycznego, CeDeWu, Warszawa 2010.
• Makowska M., Etyczne standardy relacji pomiędzy lekarzami a firmami farmaceutycznymi w Stanach Zjednoczonych, "Annales. Etyka w życiu gospodarczym" 2008, t. 2, nr 11, s. 75-87.
• McCormick B., Tomlinson G., Brill-Edwards P., Detsky A., Effect of Restricting Contact between Pharmaceutical Company Representatives and Internal Medicine Residents on Post-training Attitudes and Behavior, "Journal of the American Medical Association" 2001, No. 286 (16), s. 1994-1999.
• Orlowski J., Wateska L., The Effects of Pharmaceutical Firm Enticements on Physicians Prescribing Patterns. There's No Such Thing as a Free Lunch, "Chest" 1992, No. 102, p. 270-273. doi:10.1378/chest.102.1.270.
• Sierles F.S., Brodkey A., Cleary L.M., McCurdy F.A. et al., Medical Students' Exposure to and Attitudes About Drug Company Interactions. A National Survey, "Journal of American Medical Association" 2005, No. 294 (9), s. 1034-1042.

Identyfikatory

DOI

11089/5672